Latest Earnings Results: Q3 '26
Estimated EPS
$0.75
Reported EPS
$0.80
Surprise
+6.77%
Estimated Rev
$1.16B
Reported Rev
$1.41B
Surprise
+22.03%
• Reported GAAP EPS of $1.99 down -45.48% YoY • Reported revenue of $1.49B down -16.21% YoY • BioNTech raised its FY 2026 revenue guidance midpoint to 17T; adjusted R&D expenses guidance of 20T and adjusted SG&A expenses guidance of 700.8B remain unchanged for the full year.
Generated by Stocktwits using AI and company-reported earnings data for Q3 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q4 '26 | -$1.87 | -- | -- | N/A |
Q3 '26 | $0.75 | $0.80 | 6.77% | BEAT |
Q2 '26 | -$3.73 | -$3.63 | 2.77% | BEAT |
Q1 '26 | -$2.57 | -$2.42 | 5.66% | BEAT |
Q4 '25 | -$0.19 | -$1.46 | -666.92% | MISSED |